20th August 2008 @ 1:35am
 Subscribe | Instructions To Authors | Advertising/Supplements | Contact Us | Help

Volume 2, Number 5, October-November 2005


BACK TO BASICSAspirin in CVD prevention

POPULAR
TOPIC
DISEASE FOCUSVenous leg ulcers
Mike Kirby & Sandy Wilson

Chronic leg ulcers are a major health problem in the UK, affecting many older people and costing the NHS up to £600 million per year. Chronic leg ulcers are generally managed in primary care: more than 80% of chronic leg ulcers are cared for in the community. Healing rates are currently low and recurrence rates are higher than 67%. However, appropriate use of available treatments can reduce recurrence rates to between 20% and 30%. In this article, we review the causes of venous ulceration, how to spot the problem early and how to optimise leg ulcer healing.

EDITORIALEditorial
Jan Procter-King

All in all, it’s been a good year for primary care in the UK. Results from the first year of the Quality and Outcomes Framework (QOF) showed practices have performed much better than anyone expected in terms of delivering very high quality care. BJPCN is designed to help you keep hitting the challenging targets practice teams will be aiming for in the year ahead.

POPULAR
TOPIC
EDITORIALScoring QOF points for diabetes
Stewart Findlay

IIn this, the fifth article in our series on the Quality and Outcomes Framework (QOF), we review how to score top points for diabetes. This is an area that has been managed almost wholly in Primary Care for many years. Virtually all practices now have a diabetes clinic, which generally has extensive nurse involvement – with many being nurse-led. Practices are doing extremely well in this area and many are achieving a very high percentage of points. Figures for practices in England showed that on average they scored 93.2% of the QOF points for diabetes. This article offers some pointers on how to keep up the good work.

POPULAR
TOPIC
EDITORIALGoing for gold: reducing cardiovascular risk with physical activity
Catherine Robertson

Physical activity reduces the risk of developing heart disease and lowers the risk of death and further events in patients with cardiovascular conditions. This article reviews the benefits of exercise and shares some of the strategies our team uses to help patients with heart disease increase their levels of physical activity and keep active after they have completed phase 3 cardiac rehabilitation.

FOOD FOR THOUGHTFaddy diets: fact or fiction?
Sara Harrison

An estimated two-thirds of the population are thinking about, or trying to lose weight at any time. To meet this demand, there is a growing range of commercial and ‘fad’ diets available but, unfortunately, very little research to indicate what works and what doesn’t. This article looks at some of the more popular fad and commercial diets you may be asked about in clinic, giving you the information you need to have a discussion about the pros and cons of different weight loss methods with your patients, to help them lose weight and keep it off. The key finding seems to be – if it sounds too good to be true, it probably is!

EVIDENCE IN PRACTICEEvidence in Practice
There are just not enough hours in the day to read all the research journals, even if you wanted to. This section of the BJPCN – Evidence in Practice – will keep you on top of relevant research without having to spend hours in the library. Each journal review gives you a bite-size summary of new research, pulling out key points for primary care and recommending the action that you might consider taking.

POPULAR
TOPIC
THERAPEUTICS REVIEWWhich antihypertensives are best? Making sense of the ASCOT study
Mike Kirby & Carole McCallum

'Newer’ antihypertensive therapy reduces cardiovascular events compared to ‘older’ drugs, according to the recently published Anglo-Scandinavian Cardiac Outcomes Trial – Blood Pressure Lowering Arm (ASCOT-BPLA). The results showed that antihypertensive therapy based on the calcium channel blocker amlodipine, with the ACE inhibitor perindopril added as required, reduced cardiovascular events compared with treatment based on the beta-blocker atenolol. In this article, we review what the findings mean for primary care management of high blood pressure and put them in perspective.